Exercise-Based Cardiac Rehabilitation for Patients With Heart Failure With Preserved Ejection Fraction (EMPOWER-HFpEF) | MicrobiomeTrials← Back to trialsNCT07727096
Exercise-Based Cardiac Rehabilitation for Patients With Heart Failure With Preserved Ejection Fraction (EMPOWER-HFpEF)
RecruitingNAINTERVENTIONAL
Trial Details
Start: 2026-09-01Est. Completion: 2031-09-01
Enrollment target: 390 participants Other microbiome trials you might be interested in
Heart Failure NYHA Class III
This is a prospective, multi-center, open-label, single-arm CE-Mark trial to assess device safety and efficacy of the Co…
Aalst, BelgiumEst. completion Oct 30, 2021
Sustained Monomorphic VT (MMVT)Recurrent Ventricular Tachycardia
This is a multicenter, prospective, parallel, randomized controlled trial to test for non-inferiority with an ILAM-guide…
Phoenix, United StatesEst. completion Apr 30, 2028
Diffuse Large B-cell Lymphoma (DLBCL)CardiotoxicityLymphoma
This trial is to evaluate if dexrazoxane is safer and more effective than liposomal doxorubicin in preventing heart fail…
Boston, United StatesEst. completion Dec 31, 2030